1. Home
  2. FRHC vs CYTK Comparison

FRHC vs CYTK Comparison

Compare FRHC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freedom Holding Corp.

FRHC

Freedom Holding Corp.

HOLD

Current Price

$133.20

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.42

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRHC
CYTK
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FRHC
CYTK
Price
$133.20
$63.42
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$82.38
AVG Volume (30 Days)
111.1K
2.2M
Earning Date
02-06-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,563,510,000.00
$87,211,000.00
Revenue This Year
N/A
$346.43
Revenue Next Year
N/A
$57.69
P/E Ratio
$1,718.95
N/A
Revenue Growth
16.04
2609.26
52 Week Low
$111.85
$29.31
52 Week High
$194.01
$70.98

Technical Indicators

Market Signals
Indicator
FRHC
CYTK
Relative Strength Index (RSI) 48.95 50.34
Support Level $131.00 $60.30
Resistance Level $138.63 $65.25
Average True Range (ATR) 5.03 2.76
MACD 0.84 0.10
Stochastic Oscillator 64.66 58.20

Price Performance

Historical Comparison
FRHC
CYTK

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: